tiprankstipranks
Trending News
More News >
Tonix Pharmaceuticals (TNXP)
:TNXP
US Market

Tonix Pharma (TNXP) Income Statement

Compare
5,021 Followers

Tonix Pharma Income Statement

Last quarter (Q3 2025), Tonix Pharma's total revenue was $3.29M, an increase of 16.58% from the same quarter last year. In Q3, Tonix Pharma's net income was $-32.01M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.09M$ 7.77M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 2.33M$ 3.03M$ 0.00$ 0.00$ -27.00K
Operating Expenses
$ 139.03M$ 121.41M$ 112.09M$ 92.31M$ 50.48M
Depreciation and Amortization
$ 3.42M$ 4.29M$ 1.25M$ 50.00K$ 27.00K
EBITDA
$ -74.32M$ -114.09M$ -110.84M$ -92.26M$ -50.44M
Operating Income
$ -136.70M$ -118.38M$ -112.09M$ -92.31M$ -50.51M
Other Income/Expenses
$ 6.67M$ 1.72M$ 1.87M$ 25.00K$ 48.00K
Pretax Income
$ -130.04M$ -116.66M$ -110.22M$ -92.29M$ -50.46M
Net Income
$ -130.04M$ -116.66M$ -110.22M$ -92.29M$ -50.46M
Per Share Metrics
Basic EPS
$ -176.60$ -6.37K$ -811.68$ -163.97K$ -5.06K
Diluted EPS
$ -176.60$ -6.37K$ -811.68$ -163.97K$ -5.06K
Weighted Average Shares Outstanding
2.26M 1.83M 3.07M- 2.56M
Weighted Average Shares Outstanding (Diluted)
2.26M 1.83M 3.07M- 2.56M
Currency in USD

Tonix Pharma Earnings and Revenue History